Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Jun 27;10:3187–3192. doi: 10.2147/OTT.S139718

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2017 Zhu et al. This work is published and licensed by Dove Medical Press Limited

The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.

PMC Copyright notice

Hematoxylin–eosin staining and immunohistochemistry in small-cell cancer after crizotinib treatment.

Notes: (A) Hematoxylin–eosin staining revealed that tumor cells were lung small-cell cancer (×100). (B) Immunohistochemical examination revealed that tumor cells were positive for monoclonal anti-CD56 antibody (×100). (C) Immunohistochemical examination revealed that tumor cells were positive for monoclonal anti-Syn antibody (×200). (D) Immunohistochemical examination revealed that the tumor cell proliferation index was 98% for monoclonal anti-Ki-67 antibody (×100). (E) Immunohistochemical examination revealed that tumor cells were negative for monoclonal anti-CgA antibody (×100). (F) Immunohistochemical examination revealed that tumor cells were negative for monoclonal anti-PD-L1 antibody (×100).